NS002 — Topline data
Q1 2027
Pivotal Study is planned for the fourth quarter of 2026; topline data readout anticipated first quarter 2027Source filing
NSRX biotech catalysts & pipeline
NASUS PHARMA LTD · Data as of 2026-10-25
catalyst calendar
/
catalyst calendar
NASUS PHARMA LTD · Data as of 2026-10-25
Q1 2027
Pivotal Study is planned for the fourth quarter of 2026; topline data readout anticipated first quarter 2027Source filing